Comparison of clinical outcomes between upgraded pathologic Gleason score 3+4 and non-upgraded 3+4 prostate cancer among patients who are candidates for active surveillance

摘要

To clarify differences patients with pathological GS (pGS) 3 + 4 according to biopsy Gleason score (bGS) after radical prostatectomy (RP) among candidates for active surveillance.